WALTHAM, Mass., Oct. 30, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Wednesday, November 6 at 8:30 a.m. Eastern Time to discuss its third quarter 2013 financial results. The call and webcast will follow the release of third quarter financial results before the market opens.
Conference Call Details
To access the live conference call on November 6 at 8:30 a.m. Eastern Time via phone, please dial (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 internationally. Please dial in approximately ten minutes prior to the start of the call.To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at www.bg-medicine.com . Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. About BG Medicine BG Medicine, Inc. (Nasdaq:BGMD) is a commercial stage company focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com . The BG Medicine Inc. logo is available for download here
CONTACT: Inquiries: Chuck Abdalian, EVP & Chief Financial Officer (781) 434-0210